Nevoid Basal Cell Carcinoma Syndrome clinical trials

Explore recruiting nevoid basal cell carcinoma syndrome clinical trials.

Also recruiting in Europe

Nevoid Basal Cell Carcinoma Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II study of Sonidegib in Nevoid Basal Cell Carcinoma Syndrome (Gorlin) syndrome and sporadic BCC patients in EADO stage IIb. SIBLINGS TRIAL

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Nevoid Basal Cell Carcinoma Syndrome trials by city

Nevoid Basal Cell Carcinoma Syndrome in Toronto Nevoid Basal Cell Carcinoma Syndrome in Vancouver Nevoid Basal Cell Carcinoma Syndrome in Montreal Nevoid Basal Cell Carcinoma Syndrome in Calgary Nevoid Basal Cell Carcinoma Syndrome in Edmonton Nevoid Basal Cell Carcinoma Syndrome in Ottawa Nevoid Basal Cell Carcinoma Syndrome in Winnipeg Nevoid Basal Cell Carcinoma Syndrome in Quebec City Nevoid Basal Cell Carcinoma Syndrome in Hamilton Nevoid Basal Cell Carcinoma Syndrome in Kitchener Nevoid Basal Cell Carcinoma Syndrome in London Nevoid Basal Cell Carcinoma Syndrome in Halifax Nevoid Basal Cell Carcinoma Syndrome in New York Nevoid Basal Cell Carcinoma Syndrome in Los Angeles Nevoid Basal Cell Carcinoma Syndrome in Chicago Nevoid Basal Cell Carcinoma Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease